gvs 111 has been researched along with Memory Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belnik, AP; Ostrovskaya, RU; Radionova, KS | 1 |
| Belnik, AP; Ostrovskaya, RU; Storozheva, ZI | 1 |
| Gudasheva, TA; Ostrovskaya, RU; Romanova, GA; Shakova, FM | 1 |
| Gudasheva, TA; Halikas, JA; Ostrovskaya, RU; Romanova, GA; Seredenin, SB; Trofimov, SS; Voronina, TA | 1 |
4 other study(ies) available for gvs 111 and Memory Disorders
| Article | Year |
|---|---|
Original nootropic drug noopept prevents memory deficit in rats with muscarinic and nicotinic receptor blockade.
Topics: Animals; Cholinergic Agonists; Cholinergic Antagonists; Dipeptides; Male; Mecamylamine; Memory; Memory Disorders; Nicotinic Antagonists; Nootropic Agents; Rats; Scopolamine | 2008 |
Noopept efficiency in experimental Alzheimer disease (cognitive deficiency caused by beta-amyloid25-35 injection into Meynert basal nuclei of rats).
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Basal Nucleus of Meynert; Dipeptides; Disease Models, Animal; Humans; Male; Memory Disorders; Nootropic Agents; Peptide Fragments; Random Allocation; Rats; Rats, Wistar | 2008 |
Impairment of learning and memory after photothrombosis of the prefrontal cortex in rat brain: effects of Noopept.
Topics: Animals; Avoidance Learning; Brain Injuries; Dipeptides; Intracranial Thrombosis; Learning; Light; Male; Memory Disorders; Nootropic Agents; Prefrontal Cortex; Rats; Reaction Time; Retention, Psychology | 2002 |
The novel substituted acylproline-containing dipeptide, GVS-111, promotes the restoration of learning and memory impaired by bilateral frontal lobectomy in rats.
Topics: Animals; Dipeptides; Frontal Lobe; Learning Disabilities; Male; Memory Disorders; Motor Activity; Nootropic Agents; Rats; Rats, Wistar | 1997 |